Lv61
3030 积分 2024-07-05 加入
Emerging targeted therapies in ANCA-associated vasculitis
8天前
已完结
The complement system in antineutrophil cytoplasmic antibody-associated vasculitis: pathogenic player and therapeutic target
8天前
已完结
ARE ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIDES PAUCI-IMMUNE?
19天前
已完结
Complement in ANCA-associated glomerulonephritis
19天前
已完结
Advances in the treatment of ANCA-associated vasculitis
20天前
已完结
Diagnosis and management of ANCA-associated vasculitis
20天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
1个月前
已完结
Anti-neutrophil cytoplasmic antibody-associated vasculitis complicated by thrombotic microangiopathy with posterior reversible encephalopathy syndrome successfully treated with eculizumab: A case report
1个月前
已完结
Glucocorticoid-free induction regimen in severe ANCA-associated vasculitis using a combination of rituximab and eculizumab
1个月前
已完结
Therapeutics controversies in antineutrophilic cytoplasmic antibody-associated vasculitis
1个月前
已完结
皖公网安备34019202002308
